All you need is light, antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease

Tyler G. St. Denis, Tianhong Dai, Leonid Izikson, Christos Astrakas, Richard Rox Anderson, Michael R. Hamblin, George P. Tegos

Research output: Contribution to journalReview articlepeer-review

200 Citations (Scopus)


The story of prevention and control of infectious diseases remains open and a series of highly virulent pathogens are emerging both in and beyond the hospital setting. Antibiotics were an absolute success story for a previous era. The academic and industrial biomedical communities have now come together to formulate consensus beliefs regarding the pursuit of novel and effective alternative anti-infective countermeasures. Photodynamic therapy was established and remains a successful modality for malignancies but photodynamic inactivation has been transformed recently to an antimicrobial discovery and development platform. The concept of photodynamic inactivation is quite straightforward and requires microbial exposure to light energy, typically wavelengths in the visible region, that causes the excitation of photosensitizer molecules (either exogenous or endogenous), which results in the production of singlet oxygen and other reactive oxygen species that react with intracellular components, and consequently produce cell inactivation. It is an area of increasing interest, as research is advancing (1) to identify the photochemical and photophysical mechanisms involved in inactivation, (2) to develop potent and clinically compatible photosensitizer, (3) to understand how photoinactivation is affected by key microbial phenotypic elements (multidrug resistance and efflux, virulence and pathogenesis determinants, biofilms), (4) to explore novel delivery platforms inspired by current trends in pharmacology and nanotechnology and (5) to identify photoinactivation applications beyond the clinical setting such as environmental disinfectants.

Original languageEnglish
Pages (from-to)509-520
Number of pages12
Issue number6
Publication statusPublished - 2011
Externally publishedYes


  • Antimicrobial resistance
  • Biofilms
  • Clinical applications
  • Drug delivery
  • Multidrug efflux systems
  • Nanomedicine
  • Permeability barrier
  • Photodynamic inactivation and therapy
  • Photosensitizer
  • Reactive oxygen species

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Immunology
  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'All you need is light, antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease'. Together they form a unique fingerprint.

Cite this